This article is more than 5 years old. Information may no longer be current.

Cloud-based imaging software cleared by FDA to assist in blood flow analysis

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Arterys announced that its cloud-based medical imaging software has been cleared by the FDA to be used for quantification of cardiac flow in clinical settings.

The system (Arterys Software) includes 4D flow and 2D phase contrast workflows, as well as cardiac function measurements, according to a press release from the company, which also stated that the system was previously cleared to provide 4D flow visualization.

The software program can analyze blood flow to the heart and vessels via multislice, multiphase and velocity-coated 4D MRIs, and has been validated with images taken from 1.5-Tesla and 3-T MRI scanners, according to the release.

The system can be used to assist clinical decision making for patients with complex congenital heart disease, shunts and collateral vessels, aortic disease and valvular disease, the company stated in the release.